相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type
Motoko Yamaguchi et al.
BLOOD (2018)
Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Current treatment approaches for NK/T-cell lymphoma
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2017)
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis
Seok Jin Kim et al.
LANCET ONCOLOGY (2016)
GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Jing-jing Wang et al.
MEDICINE (2016)
Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
Seok Jin Kim et al.
ANNALS OF HEMATOLOGY (2014)
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group
Seok Jin Kim et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2013)
Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis
H. K. Ahn et al.
ANNALS OF ONCOLOGY (2012)
Clinical features and prognostic model for extranasal NK/T-cell lymphoma
Jae-Cheol Jo et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: An Updated Analysis of the Japan Clinical Oncology Group Study JCOG0211
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
Arnaud Jaccard et al.
BLOOD (2011)
Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
R. Suzuki et al.
ANNALS OF ONCOLOGY (2010)
Non-nasal natural killer cell lymphoma: not non-nasal after all
Eric Tse et al.
ANNALS OF HEMATOLOGY (2009)
Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
Wing-yan Au et al.
BLOOD (2009)
Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
Motoko Yamaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
Seok Jin Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status
YH Ko et al.
HISTOPATHOLOGY (2004)
Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course
S Mraz-Gernhard et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
